Company / Return on Equity (ROE)
CorVel Corporation Return on Equity (ROE) History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
38.4%
FY2024
5-year range
30.1% / 38.4%
FY2020-FY2024
Trend
+1.9%
vs FY2023
Sector context
#7 of 147
Health Care
What the data says
Among 147 Health Care companies, CorVel Corporation is in the top 5% for return on equity (roe). Return on Equity (ROE) has increased for 5 consecutive years, from 24.3% in FY2019 to 38.4% in FY2024.
Based on SEC 10-K filings.
38.4% in FY2024 with a 5-year CAGR of +14.1%. Top quartile in the Health Care sector.
Improved from 31.3% to 38.4% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- +8.3pp
- 5-Year Change
- +14.1pp
- 10-Year Change
- -
Sector benchmark
Top 5% in Health CareTop 5% of 147This company 38.4% Sector average -3.1%
▼
+1331.5% above sector average
Key checks
Key Insights
- CorVel Corporation's return on equity (roe) has grown for 5 consecutive years.
- In FY2024, return on equity (roe) increased 1.9% year-over-year.
- Currently 41.6pp above the Health Care sector average.
- Lowest return on equity (roe) in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | 38.4% | +1.9% |
| FY2023 | 37.7% | +20.7% |
| FY2022 | 31.3% | +3.7% |
| FY2021 | 30.1% | +23.3% |
| FY2020 | 24.4% | +0.5% |
| FY2019 | 24.3% | -10.9% |
| FY2018 | 27.3% | +5.9% |
| FY2017 | 25.8% | +15.3% |
| FY2016 | 22.3% | +0.2% |
As of FY2024 · SEC 10-K · Updated Mar 29, 2026